Study suggests GILZ protein as a promising anti-hepatic fibrosis drug target

By | May 6, 2021
Scientists from Russia and Italy studied a new axis of the pathway that prevents the development of liver fibrosis. The role of GILZ protein in curbing the disease progression was shown in a study using mice models and confirmed by clinical data.